Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Salem I.M.; Ismail M.I.; Ghorab A.A.M.; Fouad R.; Mosbah O.; Khalifa G.; Ibraheem A.A.A.; Mahmoud M.I.; Kamal N.M.

Journal: Egyptian Journal of Hospital Medicine

Publisher: Ain Shams University Faculty of Medicine

Publication Date: 1 July 2022

Volume / Issue: Volume 88 / Issue 1

Pages: 4062–4067

ISSN: 16872002

DOI: 10.21608/EJHM.2022.254086

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access


Authors and Affiliations

Salem I.M., Department of1Internal Medicine and Nephrology Faculty of Medicine, Zagazig University, Egypt; Ismail M.I., Department of1Internal Medicine and Nephrology Faculty of Medicine, Zagazig University, Egypt; Ghorab A.A.M., Department of1Internal Medicine and Nephrology Faculty of Medicine, Zagazig University, Egypt; Fouad R., Department of Hematology, Theodor Bilharez Research Institute, Cairo, Egypt; Mosbah O., Department of Internal Medicine and Nephrology, Theodor Bilharez Research Institute, Cairo, Egypt; Khalifa G., Department of Internal Medicine and Nephrology, Theodor Bilharez Research Institute, Cairo, Egypt; Ibraheem A.A.A., Department of Nephrology, Theodor Bilharez Research Institute, Cairo, Egypt; Mahmoud M.I., Department of1Internal Medicine and Nephrology Faculty of Medicine, Zagazig University, Egypt; Kamal N.M., Department of1Internal Medicine and Nephrology Faculty of Medicine, Zagazig University, Egypt


Abstract

Background: A common consequence of diabetes is diabetic kidney disease (DKD). Increased Lp-PLA2 plasma levels have been related to higher risk of development of DKD in type 2 diabetes patients. Objective: To illustrate the significance of using lipoprotein phospholipase A2 as potential early biomarker for detecting diabetic nephropathy among type 2 diabetic patients. Patients and methods: A case-control study were conducted at the nephrology unit in partnership with Theodor Bilharz Research Institute and the Internal Medicine Department of Zagazig University Hospitals. This study was performed on (33) type 2 diabetic patients and were compared with 11 healthy subjects who were matched age, sex as a control group. Plasma LP-PLA2 was assessed among all subjects. Results: It is more common in diabetic patients to have elevated plasma LP-PLA2 levels than in healthy people. LP-PLA2 levels were much higher in diabetic patients with microalbuminuria than in those with normoalbuminuria, and higher with macroalbuminuria than with microalbuminuria. Plasma LP-PLA2 levels were correlated to creatinine, urea and UACR reflecting that it is a marker of early nephropathy. The ROC curve for the validity of plasma LP-PLA2 in detecting kidney disease in type2 diabetic patients with micro and macroalbuminuria showed high specificity and sensitivity. Conclusion: LP-PLA2 could be considered an early indicator of diabetic nephropathy in patients with type 2 diabetes. © 2022, Ain Shams University Faculty of Medicine. All rights reserved.


Keywords

Diabetic Kidney Disease; Lipoprotein-associated Phospholipase A2; Type 2 Diabetes


Citation Information

Scopus Citations: 1


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer